Pre-operative fractionated stereotactic radiotherapy (FSRT) may produce better outcomes than post-operative FSRT in cancer patients with brain metastases.
Gross profit increased by 20.3% to HK$205.9 million- Consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million- Interim dividend of HK5.50 cents per share, up by 59.4% ...
Nanoform Finland Plc. November 18, 2024. 08:10 a.m. Finnish time / 07:10 a.m. Swedish time. Nanoform Q3 2024 report: Record number of new projects signed. A ...
A recent analysis published by Wiley online in CANCER reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between ...
Tumour-suppressor proteins act to alleviate the potential for cancer and tumour formation by modulating cell growth either through negative regulation of the cell cycle or by promoting apoptosis ...
Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% Y/Y Reiterates guidance to ...
DUBLIN, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...